Revolutionizing Cardiovascular, Renal & Metabolic Care

 

Join the frontline of medical innovation in CVRM R&D

California

United States
As the cornerstone of our company, Company Engineers always aspire to be the best in the industry. Whether coding, building, hacking, designing, or testing

Benefits

Open positions
Shape the future of CVRM care
Cardiovascular, renal, and metabolic (CVRM) diseases are rapidly emerging as a global public health crisis, affecting at least half of the world's population. These conditions lead to severe health complications and early mortality. Despite advancements in medical treatments, CVRM diseases frequently go undiagnosed and undertreated, resulting in escalating healthcare costs and an increasing societal burden. Prioritizing CVRM diseases on national health agendas is more critical than ever, as their expanding impact makes them one of the most pressing global health challenges today.
img1

"Roche has more than 30 years of experience developing innovative treatments for respiratory diseases. We are committed to applying our expertise to understand the immune mechanisms that drive COPD, so that we can bring positive change for physicians, their patients, and health care systems."
Larry Tsai
Senior Vice President and Global Head of Immunology, Product Development

Our approach

We support individuals with CVRM diseases at every stage, from diagnosis to ongoing monitoring. Our advanced diagnostics and investigational medicines show promising early benefits. By setting new standards of care, we aim to improve patient outcomes and reduce the societal burden of CVRM diseases.

Diagnose

Advanced diagnostics provide precise detection

Treatment

Targeted treatment offers effective management

Monitoring

Continuous monitoring to ensure an optimal outcome
A sense of mutual respect and mindfulness permeates our culture-in fact, it’s the key to our success.
See more
ManuChakravarthy

"At Roche, thanks to our pharmaceutical and diagnostics divisions being under the same roof, exciting collaborations are taking place to reimagine how we approach cardiometabolic care as a whole to address the unmet needs of people living with obesity, diabetes, cardiovascular and kidney disorders. The goal is to move beyond treating these diseases as separate and instead provide holistic and personalised support from early diagnosis and treatment through to monitoring. By that we’re not just developing new treatment options, we’re building an innovative, holistic framework for long-term care that adapts to the patient, not the other way around."
Dr. Manu Chakravarthy
Senior Vice President and Global Head of Cardiovascular, Renal and Metabolism Product Development

Our approach

From diagnosis, to treatment to monitoring: we support people living with cardiometabolic diseases at every step of their way. 

Diagnosis

Advanced diagnostics provide precise detection

Treatment

Targeted treatment offers effective disease management

Monitoring

Continuous monitoring to ensure an optimal outcome
A sense of mutual respect and mindfulness permeates our culture-in fact, it’s the key to our success.

Heading

Your path to innovation with Roche

Our combined strength in pharmaceuticals, diagnostics, and digital expertise offers you a unique opportunity to create innovative solutions that transform patient care.

Here’s what we offer:
  • Cutting-edge innovation: Join a team at the forefront of developing advanced treatments for CVRM diseases, driving significant advancements that can transform patient care.
  • A global platform: Work on an international scale, collaborating across markets to bring groundbreaking treatments to patients.
  • A culture of excellence: Join a company known for its strong values, commitment to innovation, and investment in employee growth.
A sense of mutual respect and mindfulness permeates our culture-in fact, it’s the key to our success.

Heading

Make a difference in respiratory health

Our work in addressing Chronic Obstructive Pulmonary Disease is part of a long-term strategic commitment, providing a stable and exciting career opportunity for those looking to make a meaningful impact.

Here’s what we offer:

  • Cutting-edge innovation: Be part of a team leading advancements in biologics for COPD treatment.
  • A global platform: Work on an international scale, collaborating across markets to bring groundbreaking treatments to patients.
  • A culture of excellence: Join a company known for its strong values, commitment to innovation, and investment in employee growth.
A sense of mutual respect and mindfulness permeates our culture-in fact, it’s the key to our success.
CVRM Stories Improving Hypertension Care

With over a billion adults affected, hypertension is the leading preventable cause of cardiovascular diseases (CVD) and 10 million avoidable deaths yearly. Tackling this crisis is key to reducing the global CVD burden. How can we change the trajectory of hypertension and improve patient care?

Learn more
  • 2022年设立，是中国医疗行业首个面向教授的人才培养基金
  • 助力中国医药卫生事业高层次人才队伍建设，建立国家公共卫生和卫生健康管理政策智库
  • 截止至2025年1月，共支持了30余位来自群医学及公共卫生领域高层次人才
CVRM Stories Obesity: How can we change the trajectory to improve people's lives across the world? 

With over 4 billion people projected to be affected by 2035, obesity is linked to 200+ comorbidities, including type 2 diabetes, cardiovascular disease, and cancer. As the numbers rise, the strain on healthcare systems grows—so how can we address this urgent challenge?

Read more
  • 2003年设立，是中国医疗行业首个由企业颁发且历史最悠久的教育奖学金
  • 20+年持续培养，为中国医疗教育研究事业储备优秀人才
  • 截止至2025年1月，共支持了来自24所大学的2,300余名学子
CVRM Stories Diagnostics in cardiometabolic disease

We live in an increasingly on-demand world. Everything from food to furniture can be accessed from the comfort of our homes, but how might this sedentary lifestyle impact our health?

Learn more
  • 2022年设立，是中国医疗行业首个面向教授的人才培养基金
  • 助力中国医药卫生事业高层次人才队伍建设，建立国家公共卫生和卫生健康管理政策智库
  • 截止至2025年1月，共支持了30余位来自群医学及公共卫生领域高层次人才
CVRM Stories Roche Genentech Innovation Center

The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and Metabolism, as well as for data science and AI specialists to drive innovation in drug discovery and development.

Learn more
  • 2022年设立，是中国医疗行业首个面向教授的人才培养基金
  • 助力中国医药卫生事业高层次人才队伍建设，建立国家公共卫生和卫生健康管理政策智库
  • 截止至2025年1月，共支持了30余位来自群医学及公共卫生领域高层次人才

Explore career opportunities and become part of a transformative journey in CVRM treatment.

Employee Engagement

Explore career opportunities and become part of a transformative journey in CVRM treatment.